GB Sciences is a dedicated plant-based research and biopharmaceutical drug development company, paving the way for the future of healing. Their mission is to create patented formulations of plant-inspired, minimum essential mixtures to be used as prescription medications. They have achieved significant results in their Animal Proof-of-Concept Study for Parkinson's Disease therapies and were granted a US Patent in 2020.

GB Sciences aims to initiate their First-in-Man trial as soon as possible. In 2021, they also achieved positive proof-of-concept results for therapies designed to suppress COVID-Related Hyperinflammation. GB Sciences utilizes AI technology through their PhAROS Drug Discovery Platform to identify and predict the efficacy of combinations of novel active ingredients from plants.

With a strong focus on research and development, they collaborate with world-class researchers from international universities to create the future of medicine. Their goal is to produce next-generation plant-inspired medicines that combine the benefits of plant-based medicine with the advancements of science